AVAI
AVAI BIO, INC.
+0.01 (+4.65%)0.15USD1成交股數22.9M市值–本益比(近四季)82.8股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 3 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | 0 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | 1.00 |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | 24K | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 176K | 190K | 265K | 214K | −175K | 260K | 423K | 255K | 986K | 372K | 361K | 87K |
| 營業利益 | −552K-67% | −554K-222% | −453K-173% | 488K-192% | −1.7M-267% | 452K+13% | 623K+51% | −529K-8% | 1.0M | 400K | 412K | −573K |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −552K-219% | −554K+22% | −453K-28% | 488K-192% | 464K-146% | −452K+13% | −625K+52% | −529K+323% | −1.0M | −400K | −412K | −125K |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋股數 | – | – | – | – | – | – | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 84K | 50K | 92K | 10K | 81K | 3K | 2K | 444.00 | 896.00 | 1K | 518.00 | 107K |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 792K | 173K | 231K | 145K | 225K | 175K | 181K | 245K | 291K | 265K | 274K | 241K |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 4.0M | 3.0M | 2.5M | 2.1M | 1.8M | 2.3M | 2.0M | 2.3M | 1.7M | 1.3M | 1.3M | 875K |
| 股東權益 | −3.2M | −2.8M | −2.3M | −2.0M | −1.6M | −2.1M | −1.8M | −2.1M | −1.4M | −991K | −994K | −633K |
| 負債比 | 507.0% | 1,716.1% | 1,094.4% | 1,470.5% | 795.8% | 1,321.1% | 1,101.7% | 951.2% | 581.0% | 474.0% | 462.1% | 362.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 27Q1 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −414K | – | – | −240K+1792% | – | – | – | −13K | – | – | −60K | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | 5K | 7K | 7K | 7K | 16K | 20K | 20K | 20K | 10K | 10K | 9K | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | – | – | −1.7M | –% | – | – |
| FY2025 | – | – | −1.1M | –% | – | – |
| FY2024 | – | – | −2.1M | –% | – | – |
| FY2024 | – | – | −1.8M | –% | – | – |
| FY2023 | 276K | -70.0% | −349K | -126.3% | – | – |
| FY2022 | 921K | -24.1% | −127K | -13.7% | – | – |
| FY2021 | 1.2M | -15.4% | −302K | -24.9% | – | – |
| FY2020 | 1.4M | – | −70K | -4.9% | 0.00 | 131K |